Telcare connects the last mile between patients with chronic illness and their caregivers using cellular-enabled solutions. Telcare’s blood glucose meter for people with Diabetes was cleared by FDA in July 2011 and is the world’s first device to automatically transmit blood glucose results to a physician or other caregiver and return immediate feedback to the screen of the meter. More that 28 million Americans have diabetes and the global market for glucose testing devices and supplies exceeds $12 billion. Telcare has won multiple awards for best product from the CTIA, Frost and Sullivan, and Triple Tree.
|12/01/10||Series A||4.6M||Qualcom Ventures, Private Investors||Unknown|
|08/01/12||Series B||25.5M||Sequoia Capital, Qualcomm Life Fund||Unknown|